The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Auron Therapeutics
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bayer; BioLineRx; Celgene; Daiichi Sankyo; Novartis; Pfizer; PTC Therapeutics; Syros Pharmaceuticals
Research Funding - Agios; Amgen; Bayer; Celgene; Syros Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Novartis; Syros Pharmaceuticals
Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study.
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Amgen; Amphivena; argenx; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; Bayer; Bayer; Celgene; Celltrion; Daiichi Sankyo; Eisai; Genentech/Roche; Genoptix; Janssen; Jazz Pharmaceuticals; MedImmune; MEI Pharma; Novartis; Orsenix; Otsuka; Pfizer; Roche; Sandoz; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); amphivena (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); Cellectis (Inst); CTI (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Amphivena; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech; Sandoz; Sunesis Pharmaceuticals
 
Courtney Denton Dinardo
Honoraria - Abbvie; Agios; Bayer; Celgene; Karyopharm Therapeutics; MedImmune
Consulting or Advisory Role - Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Eytan M. Stein
No Relationships to Disclose
 
Stéphane de Botton
Honoraria - Abbvie; Agios; Bayer; Carthagenetics; Celgene; FORMA Therapeutics; Novartis; Pfizer; Pierre Fabre; Seagen; SERVIER
Consulting or Advisory Role - Agios; Bayer; Carthagenetics; Celgene; FORMA Therapeutics; Novartis; Pfizer; Pierre Fabre; Seagen; SERVIER
Speakers' Bureau - Abbvie
Research Funding - Agios
Travel, Accommodations, Expenses - Agios; Carthagenetics; Celgene; FORMA Therapeutics; Novartis; Pfizer; Pierre Fabre; Seagen; SERVIER
 
Alice S. Mims
Consulting or Advisory Role - Agios
Speakers' Bureau - Novartis
 
Gabrielle T. Prince
No Relationships to Disclose
 
Jessica K. Altman
Consulting or Advisory Role - Agios; Astellas Pharma; Celgene; GlycoMimetics; Novartis; Theradex
Research Funding - Agios (Inst); Ambit BioSciences (Inst); ARIAD (Inst); Astellas Pharma (Inst); BiolineRx (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cyclacel (Inst); MethylGene (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Biosight
 
Martha Lucia Arellano
Research Funding - Cephalon (Inst)
 
Harry Paul Erba
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Jazz Pharmaceuticals; Macrogenics; Novartis; Pfizer; Seagen
Speakers' Bureau - Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Agios (Inst); Amgen (Inst); Daiichi Sankyo (Inst); Glycomimetics (Inst); Immunogen (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Takeda (Inst)
Other Relationship - Celgene; Glycomimetics
 
Daniel Aaron Pollyea
Consulting or Advisory Role - Abbvie; Agios; argenx; Astellas Pharma; Celgene; Celyad; Curis; Daiichi Sankyo; Gilead Sciences; Glycomimetics; Pfizer; SERVIER; Takeda
Research Funding - Agios (Inst); Pfizer (Inst)
 
Anthony Selwyn Stein
Speakers' Bureau - Amgen; Celgene; Stemline Therapeutics
 
Justin M. Watts
Consulting or Advisory Role - Celgene; Jazz Pharmaceuticals; Pfizer
Speakers' Bureau - Jazz Pharmaceuticals
Research Funding - Takeda
 
Amir Tahmasb Fathi
Honoraria - Agios; Baxalta; Merck; Seagen; Tolero Pharmaceuticals
Research Funding - Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Agios
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Martin S. Tallman
Consulting or Advisory Role - Abbvie; Arog; BioLineRx; Biosight; Cellerant; Daiichi Sankyo; Delta-Fly Pharma; KAHR Medical; NOHLA Therapeutics; Orsenix; Rigel
Research Funding - Abbvie; ADC Therapeutics; Arog; Biosight; Cellerant; Orsenix
Patents, Royalties, Other Intellectual Property - UpToDate
 
Bin Fan
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Hua Liu
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Bin Wu
Employment - Agios
Stock and Other Ownership Interests - Agios
Patents, Royalties, Other Intellectual Property - Agios
Travel, Accommodations, Expenses - Agios
 
Eyal C. Attar
Employment - Agios
Stock and Other Ownership Interests - Agios
Consulting or Advisory Role - Advance Medical
 
Richard M. Stone
Honoraria - DAVA Pharmaceuticals; Medscape; Prime Oncology; Research to Practice
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; argenx; Arog; Astellas Pharma; AstraZeneca; Celgene; Celgene/Jazz; Cornerstone Pharmaceuticals; Macrogenics; Novartis; Otsuka; Pfizer; Roche/Genentech; Stemline Therapeutics; Takeda
Research Funding - Abbvie/Genentech (Inst); Agios (Inst); Novartis (Inst)